|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.00 USD | -2.81% |
|
-0.99% | +2.04% |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 33.3 | +85.02% | 12 | ||||||
| 833.31 | +31.66% | 28 | ||||||
| 287.68 | +11.29% | 19 | ||||||
| 2,078,557 | +54.77% | 23 | ||||||
| 96.59 | +21.79% | 16 | ||||||
| 220.25 | +1.95% | 31 | ||||||
| 44.25 | -34.22% | 20 | ||||||
| 110.7 | -2.69% | 23 | ||||||
| 101.64 | +56.55% | 26 | ||||||
| 476.25 | +2.16% | 12 | ||||||
| 102.28 | +45.61% | 23 | ||||||
| 276.47 | +14.4% | 21 | ||||||
| 458,000 | +33.33% | 5 | ||||||
| 87.85 | +48.89% | 26 | ||||||
| 349.78 | -6.04% | 9 | ||||||
| 14.4 | +57.75% | 12 | ||||||
| 74.1 | -25.78% | 10 | ||||||
| - | - | 61.5 | +48.33% | 1 | ||||
| 31.4 | +127.49% | 10 | ||||||
| - | - | 40.3 | +53.41% | 1 | ||||
| Average | 126,989.95 | +31.28% | 16 | ||||||
| Weighted average by Cap. | 222,329.46 | +22.35% | 21 |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
